BG
HELP

Bollard Group’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bollard Group’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-156,954
Closed -$1.32M – 274
2025
Q2 		$1.32M Buy
+156,954
New +$1.14M 0.03% 112

Other funds holding HELP

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

Bollard Group's HELP Position: Q3 2025 in Review

Bollard Group sold out of Helus Pharma Inc. Common Stock (HELP) in Q3 2025, closing a stake of 156,954 shares — an estimated $1.32M sold.

Bollard Group first reported a position in HELP in Q2 2025 and held it in 1 quarter. The position peaked at $1.32M in Q2 2025. 74 funds tracked by Wall St. Rank hold HELP as of Q3 2025.

  • Bollard Group reported no remaining Helus Pharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Bollard Group sold 156,954 Helus Pharma Inc. Common Stock shares in Q3 2025, an estimated $1.32M.
  • Bollard Group first reported a position in Helus Pharma Inc. Common Stock in Q2 2025 and held it in 1 quarter.
  • Bollard Group's Helus Pharma Inc. Common Stock position peaked at $1.32M in Q2 2025.
  • 74 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q3 2025.

Based on Bollard Group's 13F filing for Q3 2025, filed 14 Nov 2025.